PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32814790-6	2020	We also found that the combination of smoke and morphine inhibited the expression of IL-1alpha, IL-4 and IL-17A.	Morphine	48-56	interleukin 17A	Mus musculus	105-111	
21826405-10	2011	Morphine treatment also suppressed levels of the neutrophil-inducing molecules, IL-17A and KC/CXCL1.	Morphine	0-8	interleukin 17A	Mus musculus	80-86	
21826405-11	2011	However, IL-17A(-/-) mice given morphine were not sensitized to Acintobacter infection to a greater degree than similarly treated wild-type mice.	Morphine	32-40	interleukin 17A	Mus musculus	9-15	
19995896-0	2010	Morphine disrupts interleukin-23 (IL-23)/IL-17-mediated pulmonary mucosal host defense against Streptococcus pneumoniae infection.	Morphine	0-8	interleukin 17A	Mus musculus	41-46	
19995896-3	2010	Using a well-established murine model of opiate abuse and S. pneumoniae lung infection, we explored the influence of morphine treatment on the interleukin-23 (IL-23)/IL-17 axis and related innate immunity.	Morphine	117-125	interleukin 17A	Mus musculus	166-171	
19995896-4	2010	Impairment of early IL-23/IL-17 production caused by morphine treatment was associated with delayed neutrophil migration and decreased pneumococcal clearance.	Morphine	53-61	interleukin 17A	Mus musculus	26-31	
19995896-9	2010	In conclusion, morphine treatment causes a dysfunction in IL-23-producing dendritic cells and macrophages and IL-17-producing gammadeltaT lymphocytes in response to S. pneumoniae lung infection.	Morphine	15-23	interleukin 17A	Mus musculus	110-115